Kennedy Stuart R, Blundell Toby J, Henderson Elizabeth F, Miquelot Adeline P, Steed Jonathan W
Department of Chemistry, Durham University, South Road, Durham DH1 3LE, U.K.
Cryst Growth Des. 2025 Feb 20;25(5):1614-1621. doi: 10.1021/acs.cgd.4c01715. eCollection 2025 Mar 5.
The salts of 5-ureidosalyclic acid (5-USA) form a range of pillared salt inclusion complexes from basic solvents, namely, triethylamine, piperidine, morpholine, and 4-ethylpyridine. The triethylamine derivative is unsolvated, while the other salts include 1-3 solvent molecules of formula XH(5-USA-H)·X (X = morpholine, = 1, 2, and 3 ( - ); X = 4-ethylpyridine, = 1 () and X = piperidine, = 2.5 ()). The morpholine salt expands the layered structure to include 1, 2, or 3 guests. The 5-USA anion can also act as a bidentate ligand for manganese(III), again forming highly solvated inclusion complex anions [Mn(5-USA-H)(Solv)]. When interacting strongly with the countercation, the 5-USA anions adopt an unusual carboxylate isomer form, whereas the morpholinium salt solvate (H-morpholine)[Mn(5-USA-H)(morpholine)]·2(morpholine) () is . The soft, plastic crystals of this complex gradually desolvate, losing channel morpholine and ultimately spontaneously recrystallizing as the 5-USA salt dimorpholine inclusion complex . The complex hydrogen-bonded, pillared 5-USA salts illustrate a design concept for intercalated materials of forming charged, planar layers that leave the charge-balancing counterion exposed, such that interlayer guest species must be incorporated to effectively solvate the charged moieties.
5-脲基水杨酸(5-USA)的盐可从碱性溶剂(即三乙胺、哌啶、吗啉和4-乙基吡啶)形成一系列柱状盐包合物。三乙胺衍生物未溶剂化,而其他盐包含化学式为XH(5-USA-H)·X的1 - 3个溶剂分子(X = 吗啉, = 1、2和3( - );X = 4-乙基吡啶, = 1()且X = 哌啶, = 2.5())。吗啉盐会扩展层状结构以包含1、2或3个客体。5-USA阴离子还可作为锰(III)的双齿配体,再次形成高度溶剂化的包合配合物阴离子[Mn(5-USA-H)(Solv)]。当与抗衡阳离子强烈相互作用时,5-USA阴离子会采用一种不寻常的羧酸盐异构体形式,而吗啉鎓盐溶剂化物(H-吗啉)[Mn(5-USA-H)(吗啉)]·2(吗啉)()则是 。该配合物的柔软塑性晶体逐渐去溶剂化,失去通道中的吗啉,最终自发重结晶为5-USA盐二吗啉包合配合物 。通过氢键结合的柱状5-USA盐说明了一种用于插层材料的设计理念,即形成带电荷的平面层,使电荷平衡的抗衡离子暴露在外,这样层间客体物种必须被纳入以有效溶剂化带电部分。